Literature DB >> 11819788

Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice.

X W Wang1, J H Yuan, R G Zhang, L X Guo, Y Xie, H Xie.   

Abstract

AIM: To evaluate antihepatoma effect of antisense phosphorothioate oligodeoxyribonucleotides (S-ODNs) targeted to alpha-fetoprotein (AFP) genes in vitro and in nude mice.
METHODS: AFP gene expression was examined by immunocytochemical method or enzyme-linked immunosorbent assay. Effect of S-ODNs on SMMC-7721 human hepatoma cell growth in vitro was determined using microculture tetrazolium assay. In vitro antitumor activities of S-ODNs were monitored by measuring tumor weight differences in treated and control mice bearing SMMC-7721 xenografts. Induction of cell apoptosis was evaluated by fluorescence-activated cell sorter (FACS) analysis.
RESULTS: Antisense S-ODN treatment led to reduced AFP gene expression. Specific antisense S-ODNs, but not control S-ODNs, inhibited the growth of hepatoma cells in vitro. In vitro, only antisense S-ODNs exhibited obvious antitumor activities. FACS analysis revealed that the growth inhibition by antisense S-ODNs was associated with their cell apoptosis induction.
CONCLUSION: Antisense S-ODNs targeted to AFP genes inhibit the growth of human hepatoma cells and solid hepatoma, which is related to their cell apoptosis induction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819788      PMCID: PMC4688720          DOI: 10.3748/wjg.v7.i3.345

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  [Study of alpha-fetoprotein].

Authors:  X Wang; H Xie
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1998-10

Review 2.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Authors:  C Hélène; J J Toulmé
Journal:  Biochim Biophys Acta       Date:  1990-06-21

3.  Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

Authors:  Jin-Hui Yuan; Ru-Ping Zhang; Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Dan Luo; Yong Xie; Hong Xie
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

4.  Expression of alpha fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effect of L-4 oxalysine on the expression.

Authors:  Xing-Wang Wang; Bin Xu
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

Review 5.  Several new targets of antitumor agents.

Authors:  X W Wang; B Xu
Journal:  Zhongguo Yao Li Xue Bao       Date:  1997-07

6.  Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro.

Authors:  X W Wang; H Xie
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels.

Authors:  Y Matsumoto; T Suzuki; I Asada; K Ozawa; T Tobe; I Honjo
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

8.  Primary structures of human alpha-fetoprotein and its mRNA.

Authors:  T Morinaga; M Sakai; T G Wegmann; T Tamaoki
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

9.  [Effect of alpha-fetoprotein on the growth of human hepatoma cells in vitro].

Authors:  X W Wang; H Xie
Journal:  Shi Yan Sheng Wu Xue Bao       Date:  1999-03

10.  Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization.

Authors:  A Otsuru; S Nagataki; T Koji; T Tamaoki
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

View more
  9 in total

1.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Construction and expression of recombined human AFP eukaryotic expression vector.

Authors:  Li-Wang Zhang; Jun Ren; Liang Zhang; Hong-Mei Zhang; Bin Jin; Bo-Rong Pan; Xiao-Ming Si; Yan-Jun Zhang; Zhong-Hua Wang; Yang-Lin Pan; Stephen M Festein
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells.

Authors:  Yun-Shan Wang; Xiao-Li Ma; Tong-Gang Qi; Xiang-Dong Liu; Yue-Sheng Meng; Guang-Ju Guan
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

4.  Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin.

Authors:  Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Hong Xie
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

5.  Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro.

Authors:  Xuan Wang; Fu-Kun Liu; Xi Li; Jai-Sou Li; Gen-Xin Xu
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.

Authors:  Jia-Yin Yang; Hua-You Luo; Qi-Yuan Lin; Zi-Ming Liu; Lu-Nan Yan; Ping Lin; Jie Zhang; Shong Lei
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 7.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

8.  A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma.

Authors:  Chun-Hong Ma; Wen-Sheng Sun; Pei-Kun Tian; Li-Fen Gao; Su-Xia Liu; Xiao-Yan Wang; Li-Ning Zhang; Ying-Lin Cao; Li-Hui Han; Xiao-Hong Liang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

9.  Cooperative inhibitory effects of antisense oligonucleotide of cell adhesion molecules and cimetidine on cancer cell adhesion.

Authors:  Nan-Hong Tang; Yan-Ling Chen; Xiao-Qian Wang; Xiu-Jin Li; Feng-Zhi Yin; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.